Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunosuppressive Agents”

453 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 453 results

Not applicableNot Yet RecruitingNCT07603453
What this trial is testing

Performance of Clinical Metagenomics in Stool and Urine Samples for Unexplained Diseases Diagnostic and Emerging Diseases Surveillance in Immunocompromised Patients

Who this might be right for
Primary or Secondary Immune Deficiency Including Immunosuppressive Therapy, Chemotherapy, HIV Infection
Assistance Publique - Hôpitaux de Paris 120
Testing effectiveness (Phase 2)Ended earlyNCT00365274
What this trial is testing

SGN-30 and Combination Chemotherapy in Treating Patients With Newly Diagnosed Anaplastic Large Cell Lymphoma

Who this might be right for
Anaplastic Large Cell Lymphoma
National Cancer Institute (NCI) 6
Not applicableStudy completedNCT02857907
What this trial is testing

Anti-thymocyte Globulin-induced Immune Senescence

Who this might be right for
Disorder Related to Renal Transplantation
Centre Hospitalier Universitaire de Besancon 97
Testing effectiveness (Phase 2)Looking for participantsNCT07010237
What this trial is testing

Dose-attenuated IST and Hetrombopag in Elderly (≥65 Years) Patients With Severe Aplastic Anemia

Who this might be right for
Sever Aplastic AnaemiaElderly (People Aged 65 or More)Immunosuppressive Treatment
Institute of Hematology & Blood Diseases Hospital, China 65
Testing effectiveness (Phase 2)Ended earlyNCT04200365
What this trial is testing

Itacitinib for the Treatment of Chronic Graft Versus Host Disease (cGVHD)

Who this might be right for
Chronic Graft-versus-host-disease
SCRI Development Innovations, LLC 15
Not applicableWithdrawnNCT01284257
What this trial is testing

Observational Registry Study of Renal Transplant Patients

Who this might be right for
Kidney Transplant
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT01332201
What this trial is testing

Study to Compare the Pharmacokinetics of Tacrolimus in Adult Transplant Recipients Treated With Advagraf® or Prograf®

Who this might be right for
Heart TransplantationLung TransplantationPancreas (Including SPK) Transplantation
Astellas Pharma Inc 17
Post-approval studies (Phase 4)UnknownNCT00166816
What this trial is testing

The Pharmacokinetics of Sirolimus When Combined With Cyclosporine or Tacrolimus in Renal Transplant Patients

Who this might be right for
TransplantationKidney TransplantationImmunosuppression
National Taiwan University Hospital 40
Post-approval studies (Phase 4)Study completedNCT00296296
What this trial is testing

Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM)

Who this might be right for
Kidney TransplantDiabetes Mellitus, Type 2Diabetic Nephropathy
Stanford University 29
Early research (Phase 1)Ended earlyNCT00023790
What this trial is testing

Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin

Who this might be right for
Breast CancerHead and Neck CancerLymphoma+3 more
Case Comprehensive Cancer Center 3
Post-approval studies (Phase 4)Looking for participantsNCT06354179
What this trial is testing

Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Liver Transplantation (EASY)

Who this might be right for
Liver TransplantationImmunosuppression
University Hospital, Limoges 162
Testing effectiveness (Phase 2)Study completedNCT02371434
What this trial is testing

The ONE Study nTreg Trial (ONEnTreg13)

Who this might be right for
Immunosuppressive Treatment of Living-donor Renal Transplantation
Prof. Dr. Petra Reinke 17
Testing effectiveness (Phase 2)Study completedNCT04294641
What this trial is testing

Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease

Who this might be right for
Chronic GVHD
National Cancer Institute (NCI) 10
Large-scale testing (Phase 3)Ended earlyNCT03995901
What this trial is testing

A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation

Who this might be right for
Transplanted Organ Rejection
Talaris Therapeutics Inc. 15
Testing effectiveness (Phase 2)Study completedNCT01976182
What this trial is testing

Prospective, Multicentric, Phase II Randomized Controlled Trial on Two Parallel Groups Comparing the Efficacy of Two Immunosuppressive Drugs (methotrexate, Cyclophosphamide) in Large Granular Lymphocytes Leukemia

Who this might be right for
Large Granular Lymphocytes Leukemia
Rennes University Hospital 166
Testing effectiveness (Phase 2)Study completedNCT00683046
What this trial is testing

T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies

Who this might be right for
Acute Myelogenous LeukemiaLymphoid LeukemiaChronic Myelogenous Leukemia+6 more
University of Chicago 204
Not applicableStudy completedNCT05195086
What this trial is testing

A Pharmacoeconomic Study Comparing the Use of Mycophenolate Mofetil or Cyclophosphamide as Induction Therapy in Lupus Nephritis Patients in Egypt

Who this might be right for
Lupus Nephritis
Nada Magdy Mansour 122
Large-scale testing (Phase 3)Ended earlyNCT01765842
What this trial is testing

Comparison of the Efficacy of Two Rituximab Treatment Regimens in Patients With Lupus Nephropathy

Who this might be right for
Lupus Nephritis
Fundación Pública Andaluza Progreso y Salud 9
Not applicableStudy completedNCT03558373
What this trial is testing

The Adherence of Immunosuppressive Therapy Including Tacrolimus Once-daily in Italian Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Chiesi Farmaceutici S.p.A. 158
Testing effectiveness (Phase 2)Active Not RecruitingNCT02979873
What this trial is testing

Sirolimus (Rapamune ) for Relapse Prevention in People With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy

Who this might be right for
Severe Aplastic Anemia
National Heart, Lung, and Blood Institute (NHLBI) 84
Next Page